HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Q Li Selected Research

Type 2 Diabetes Mellitus (MODY)

7/2021Correlation Between Serum 25(OH)D and Abdominal Visceral Fat Area in Patients with Type 2 Diabetes Mellitus in the Context of different Bone Mass.
1/2020Association of C-peptide with diabetic vascular complications in type 2 diabetes.
4/2018[An efficacy and safety study of bifidobacterium tetragenous viable bacteria tablets in the treatment of constipation in patients with type 2 diabetes mellitus].
12/2016Sodium-glucose co-transporter-2 inhibitors suppress atrial natriuretic peptide secretion in patients with newly diagnosed Type 2 diabetes.
1/2016Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study (VISION).
4/2015Relationship between serum GAD-Ab and the genetic polymorphisms of GAD2 and type 2 diabetes mellitus.
1/2015Comparison of the effects on glycaemic control and β-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study).
5/2014Association between endogenous secretory receptor for advanced glycation-end products (esRAGE) and carotid intima-media thickness in type 2 diabetes.
2/2013Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes.
7/2012Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Q Li Research Topics

Disease

115Neoplasms (Cancer)
11/2023 - 01/2000
37Infections
02/2024 - 02/2001
31Breast Neoplasms (Breast Cancer)
08/2023 - 02/2000
24Inflammation (Inflammations)
03/2024 - 01/2000
22Neoplasm Metastasis (Metastasis)
07/2022 - 09/2000
22Carcinoma (Carcinomatosis)
07/2022 - 03/2000
18Type 2 Diabetes Mellitus (MODY)
07/2021 - 05/2001
17Hepatocellular Carcinoma (Hepatoma)
11/2023 - 09/2000
17Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 03/2001
16Carcinogenesis
01/2020 - 04/2000
15Ischemia
01/2019 - 02/2000
13Fibrosis (Cirrhosis)
12/2023 - 06/2000
13Hypertension (High Blood Pressure)
12/2023 - 06/2013
13Body Weight (Weight, Body)
12/2022 - 09/2000
13Lung Neoplasms (Lung Cancer)
10/2022 - 04/2000
12Insulin Resistance
11/2023 - 11/2006
12Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 09/2007
12Obesity
08/2022 - 07/2002
12Stomach Neoplasms (Stomach Cancer)
07/2022 - 03/2005
11Ischemic Stroke
05/2024 - 02/2000
11Necrosis
07/2021 - 03/2000
10Stroke (Strokes)
05/2022 - 05/2012
10Prostatic Neoplasms (Prostate Cancer)
04/2019 - 05/2008
9Hypoxia (Hypoxemia)
05/2024 - 03/2001
9Wounds and Injuries (Trauma)
09/2023 - 02/2014
9Hemorrhage
07/2023 - 09/2015
9Pain (Aches)
01/2023 - 08/2012
9Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 09/2009
9Brain Ischemia (Cerebral Ischemia)
11/2020 - 03/2000
9Thrombosis (Thrombus)
09/2020 - 04/2000
9Adenocarcinoma
08/2020 - 04/2000
9Leukemia
06/2020 - 05/2000
8Pathologic Constriction (Stenosis)
08/2023 - 02/2001
8Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 07/2003
8Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 01/2000
7Liver Cirrhosis (Hepatic Cirrhosis)
11/2023 - 06/2000
7Burns
09/2023 - 03/2017
7Myocardial Infarction
07/2023 - 04/2001
7Hepatitis B
03/2023 - 02/2009
7Melanoma (Melanoma, Malignant)
11/2022 - 04/2000
7Sepsis (Septicemia)
08/2022 - 07/2000
7Reperfusion Injury
12/2016 - 09/2001
6Anemia
02/2024 - 01/2014
6Tuberculosis (Tuberculoses)
12/2023 - 10/2000
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2023 - 01/2000
6Pneumonia (Pneumonitis)
11/2022 - 01/2014
6Osteoarthritis
01/2022 - 08/2014
6Heart Failure
08/2020 - 07/2006
5COVID-19
02/2024 - 08/2020

Drug/Important Bio-Agent (IBA)

55Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2000
26CytokinesIBA
03/2024 - 01/2000
25Messenger RNA (mRNA)IBA
05/2023 - 08/2000
22Biomarkers (Surrogate Marker)IBA
02/2024 - 07/2008
19Glucose (Dextrose)FDA LinkGeneric
01/2023 - 05/2001
16DNA (Deoxyribonucleic Acid)IBA
12/2021 - 01/2000
15LipidsIBA
11/2023 - 02/2001
15Long Noncoding RNAIBA
12/2021 - 01/2011
14VaccinesIBA
07/2022 - 04/2000
11RNA (Ribonucleic Acid)IBA
05/2024 - 10/2001
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2023 - 09/2000
11Cisplatin (Platino)FDA LinkGeneric
05/2021 - 03/2000
11MicroRNAs (MicroRNA)IBA
10/2020 - 03/2012
11AntigensIBA
01/2018 - 07/2000
10Oxygen (Dioxygen)IBA
12/2023 - 02/2000
8ChemokinesIBA
12/2023 - 07/2003
8Hormones (Hormone)IBA
08/2023 - 07/2000
8Interleukin-6 (Interleukin 6)IBA
08/2022 - 01/2000
8InterleukinsIBA
07/2021 - 06/2003
8Neuroprotective AgentsIBA
11/2020 - 02/2000
8CholesterolIBA
08/2016 - 02/2001
7Monoclonal AntibodiesIBA
02/2024 - 02/2008
7Tyrosine Kinase InhibitorsIBA
11/2023 - 01/2012
7LDL CholesterolIBA
12/2022 - 02/2016
7HDL CholesterolIBA
12/2022 - 02/2013
7Immunoglobulin G (IgG)IBA
08/2022 - 05/2011
7CateninsIBA
10/2020 - 04/2014
7Insulin (Novolin)FDA Link
01/2020 - 09/2008
7EnzymesIBA
12/2015 - 10/2000
6PlatinumIBA
08/2023 - 03/2000
6Paclitaxel (Taxol)FDA LinkGeneric
08/2023 - 08/2015
6Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 01/2006
6Triglycerides (Triacylglycerol)IBA
12/2022 - 09/2008
6GlucocorticoidsIBA
08/2022 - 03/2000
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 07/2000
6Peptides (Polypeptides)IBA
05/2021 - 01/2000
6AntibodiesIBA
12/2020 - 05/2011
6ErbB Receptors (EGF Receptor)IBA
09/2020 - 09/2001
6tildrakizumabIBA
01/2020 - 10/2015
6Indicators and Reagents (Reagents)IBA
11/2018 - 04/2004
5AlbuminsIBA
11/2023 - 03/2016
5Immune Checkpoint InhibitorsIBA
11/2023 - 07/2020

Therapy/Procedure

71Therapeutics
09/2023 - 03/2000
26Drug Therapy (Chemotherapy)
11/2023 - 03/2001
11Immunotherapy
11/2023 - 10/2000
11Transplantation
09/2023 - 10/2000
11Radiotherapy
04/2023 - 02/2007
9Stents
08/2023 - 08/2012
8Length of Stay
09/2023 - 12/2000
8Aftercare (After-Treatment)
09/2022 - 03/2005
5Renal Dialysis (Hemodialysis)
12/2023 - 11/2016